We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

FURTHER INFORMATION
 
 
 

Related Product News

2D Barcoded Tubes for Sample Storage at Ultra-Low Temperatures

Product News

The Ziath range of CryzoTraq™ 2D-barcoded cryogenic tubes aim to set a new standard for cryogenic storage of biological specimens

READ MORE

Driving Viability and Integrity In Protein Production

Product News

Lonza has expanded its cell culture media portfolio with the addition of the eCHO™ Basal Medium and Feed, designed to optimize protein production.

READ MORE

Funding to Expand Potential of Simulation-first Drug Discovery

Product News

Turbine has announced the close of its first round of funding for its redesign of the oncology drug discovery platform.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE